CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547850
- Phone
- 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +473,902 | 473,902 | ||
| 2025-04-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +473,902 | 473,902 | ||
| 2025-04-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +775,828 | 775,828 | ||
| 2025-04-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +775,828 | 775,828 | ||
| 2025-03-04 | Dalal Anupam Director | Grant or award | +1,561,000 | $2.40 | $3.7M | 3,410,402 |
| 2025-03-04 | Castelein Caley Director | Grant or award | +1,666,000 | $2.40 | $4.0M | 2,165,998 |
| 2025-03-04 | Zhao Baiteng Director | Grant or award | +1,250,000 | $2.40 | $3.0M | 1,250,000 |
| 2025-03-04 | Dornan David Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +687,979 | 687,979 | ||
| 2025-03-04 | BALL BRYAN See remarks | Grant or award | +100,000 | $2.40 | $240K | 202,853 |
| 2025-03-03 | BALL BRYAN See remarks | Sale | −2,147 | $2.35 | $5K | 102,853 |
| 2025-03-03 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Sale | −2,806 | $2.35 | $7K | 23,944 |
| 2025-03-03 | Lennon David James CHIEF EXECUTIVE OFFICER | Sale | −5,690 | $2.35 | $13K | 33,429 |
| 2025-03-01 | BALL BRYAN See remarks | Option exercise | +5,000 | 105,000 | ||
| 2025-03-01 | BALL BRYAN See remarks | Option exercise · Restricted Stock Units | −5,000 | 15,000 | ||
| 2025-03-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Option exercise | +6,750 | 26,750 | ||
| 2025-03-01 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −6,750 | 20,250 | ||
| 2025-03-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Option exercise | +16,250 | 39,119 | ||
| 2025-03-01 | Lennon David James CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −16,250 | 48,750 | ||
| 2025-02-28 | Aghazadeh Behzad Director | Grant or award · Pre-funded Warrant (right to buy) | +8,333,000 | $2.40 | $20.0M | 8,333,000 |
| 2024-12-19 | Zhao Baiteng Director | Grant or award · Stock Option (right to buy) | +61,192 | 61,192 |
Page 5 of 9 · 171 trades